Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerobic exercise plus antihypertensive therapy in premenopausal and postmenopausal women with hypertension
RBR-7fjg33Recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of enalapril and losartan in systemic arterial hypertension (HTN) and menopause (4 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Blood pressure and Heart rate. Started Jan 2019; status: recruiting.
02
Drugs
enalaprillosartan
03
Conditions
systemic arterial hypertension (HTN)menopause
Beyond the preview
Go deeper on RBR-7fjg33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7fjg33.